Viewing Study NCT01782651


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-01-05 @ 10:16 PM
Study NCT ID: NCT01782651
Status: COMPLETED
Last Update Posted: 2015-08-10
First Post: 2013-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module